Bogol, Maria Paz S.
HRN: 01-35-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2024
CEFTAZIDIME 1GM (VIAL)
03/14/2024
03/20/2024
IV
1g
Q8h
CAP HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes